Trading Signals: ALNY Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Oct. 27, 2023)(Alnylam Pharmaceuticals, Inc. )
| ALNY latest price $95.7200 (3.15%) ($95.2600 - $99.7400) on Tue. Aug. 25, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.64% (three month average) | | RSI | 50 | | Latest Price | $95.7200(3.15%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | ALNY declines -2.7% a day on average for past five trading days. | | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support ALNY advance at 0% a week (0% probability)
IBB(55%) XBI(54%) IWO(39%) XLV(36%) IWM(34%) | | Factors Impacting ALNY price | ALNY will decline at least -1.82% in a week (0% probabilities).
VIXM(-14%) IGOV(-6%) TLT(-5%) SHY(-4%) UUP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.82% (StdDev 3.64%) | | Hourly BBV | 0 () | | Intraday Trend | -2.3% | | | | | |
|
| 5 Day Moving Average | $99.87(-4.16%) | | 10 Day Moving Average | $103.7(-7.7%) | | 20 Day Moving Average | $0(0%) | | To recent high | -14.1% | | To recent low | 3.1% | | Market Cap | $11.07b | | | | | | |
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA. |